915
Views
143
CrossRef citations to date
0
Altmetric
Review Article

Health effects of inhaled engineered and incidental nanoparticles

&
Pages 629-658 | Received 19 Jan 2009, Accepted 21 Jun 2009, Published online: 11 Sep 2009

References

  • Adachi M, Murata Y, Takao J, Jiu J, Sakamoto M, Wang F. 2004. Highly efficient dye-sensitized solar cells with a titania thin-film electrode composed of a network structure of single-crystal-like TiO2 nanowires made by the “oriented attachment” mechanism. J Am Chem Soc 126:14943–14949.
  • Agrawal A, Xing Y, Gao X, Nie S. 2007. Quantum dots. In: Vo-Dinh T, ed. Nanotechnology in Biology and Medicine: Methods, Devices, and Applications. Boca Rotan, FL: CRC Press, Taylor & Francis Group pp 10–1.
  • Aitken RJ, Chaudhry MQ, Boxall AB, Hull M. 2006. Manufacture and use of nanomaterials: Current status in the UK and global trends. Occup Med (Lond) 56:300–306.
  • Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E. 2002. Nanocrystal targeting in vivo. Proc Natl Acad Sci U S A 99:12617–12621.
  • Alivisatos P. 2000. Colloidal quantum dots. From scaling laws to biological applications. Pure Appl Chem 72:3–9.
  • Andersen ZJ, Wahlin P, Raaschou-Nielsen O, Ketzel M, Scheike T, Loft S. 2008. Size distribution and total number concentration of ultrafine and accumulation mode particles and hospital admissions in children and the elderly in Copenhagen, Denmark. Occup Environ Med 65:458–466.
  • Araujo JA, Barajas B, Kleinman M, Wang X, Bennett BJ, Gong KW, Navab M, Harkema J, Sioutas C, Lusis AJ, Nel AE. 2008. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res 102:589–596.
  • ASTM International. 2006. Standard terminology relating to nanotechnology. In: Designation: E 2456–06. West Conshohocken, PA: American Society for Testing and Materials (ASTM International) pp 1–4.
  • Baker SE, Cai W, Lasseter TL, Weidkamp KP, Hamers RJ. 2002. Covalently bonded adducts of deoxyribonucleic acid (DNA) oligonucleotides with single-wall carbon nanotubes: Synthesis and hybridization. Nano Lett 2:1413–1417.
  • Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. 2004. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 15:79–86.
  • Barbeau A. 1984. Manganese and extrapyramidal disorders. Neurotoxicology 5:13–36.
  • Baughman R.H. 2000. MATERIALS SCIENCE: Putting a New Spin on Carbon Nanotubes. Science 290 (5495):1310–1311.
  • Beaurepaire E, Buissette V, Sauviat MP, Giaume D, Lahlil K, Mercuri A, Casanova D, Huignard A, Martin JL, Gacoin T, Boilot JP, Alexandrou A. 2004. Functionalized fluorescent oxide nanoparticles: Artificial toxins for sodium channel targeting and imaging at the single-molecule level. Nano Lett 4:2079–2083.
  • Bell DC, Wu Y, Barrelet CJ, Gradecak S, Xiang J, Timko BP, Lieber CM. 2004. Imaging and analysis of nanowires. Microsc Res Tech 64:373–389.
  • Bermudez E, Mangum JB, Asgharian B, Wong BA, Reverdy EE, Janszen DB, Hext PM, Warheit DB, Everitt JI. 2002. Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles. Toxicol Sci 70:86–97.
  • Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, Everitt JI. 2004. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 77:347–357.
  • Bianco A, Hoebeke J, Kostarelos K, Prato M, Partidos CD. 2005a. Carbon nanotubes: On the road to deliver. Curr Drug Deliv 2:253–259.
  • Bianco A, Kostarelos K, Partidos CD, Prato M. 2005b. Biomedical applications of functionalised carbon nanotubes. Chem Commun (Camb) 5:571–577.
  • Bianco A, Kostarelos K, Prato M. 2005c. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 9:674–679.
  • Bianco A, Prato M. 2003. Can carbon nanotubes be considered useful tools for biological applications? Adv Mater 15:1765–1768.
  • Bodian D. 1941a. Experimental studies on intraneural spread of poliomyelitis virus. Bull Johns Hopkins Hosp 69:248–267.
  • Bodian D. 1941b. The rate of progression of poliomyelitis virus in nerves. Bull Johns Hopkins Hosp 69:79–85.
  • Bottini M, Bruckner S, Nika K, Bottini N, Bellucci S, Magrini A, Bergamaschi A, Mustelin T. 2006. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol Lett 160:121–126.
  • Brain JD, Knudson DE, Sorokin SP, Davis MA. 1976. Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. Environ Res 11:13–33.
  • Brook JR, Dann TF. 1997. The relationship among TSP, PM10, PM2.5, and inorganic constituents of atmospheric particulate matter at multiple Canadian locations. J Air Waste Manage Assoc 47:2–19.
  • Brouwer DH, Gijsbers JH, Lurvink MW. 2004. Personal exposure to ultrafine particles in the workplace: Exploring sampling techniques and strategies. Ann Occup Hyg 48:439–453.
  • Brown JS, Zeman KL, Bennett WD. 2002. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med 166:1240–1247.
  • Card JW, Zeldin DC, Bonner JC, Nestmann ER. 2008. Pulmonary applications and toxicity of engineered nanoparticles. Am J Physiol Lung Cell Mol Physiol 295:L400–L411.
  • Carter JD, Qu YRP, Hoang L, Masiel DJ, Guo T. 2005. Silicon-based nanowires from silicon wafers catalyzed by cobalt nanoparticles in hydrogen environment. Chem Commun 17:2274–2276.
  • Chalupa DC, Morrow PE, Oberdorster G, Utell MJ, Frampton MW. 2004. Ultrafine particle deposition in subjects with asthma. Environ Health Perspect 112:879–882.
  • Chan CC, Chuang KJ, Shiao GM, Lin LY. 2004. Personal exposure to submicrometer particles and heart rate variability in human subjects. Environ Health Perspect 112:1063–1067.
  • Chao CC, Aust AE. 1994. Effect of long-term removal of iron from asbestos by desferrioxamine B on subsequent mobilization by other chelators and induction of DNA single-strand breaks. Arch Biochem Biophys 308:64–69.
  • Chen YF, Ji TH, Rosenzweig Z. 2003. Synthesis of glyconanospheres containing luminescent CdSe-ZnS quantum dots. Nano Lett 3:581–584.
  • Chen X, Lee GS, Zettl A, Bertozzi CR. 2004. Biomimetic engineering of carbon nanotubes by using cell surface mucin mimics. Angew Chem Int Ed Engl 43:6111–6116.
  • Cherukuri P, Gannon CJ, Leeuw TK, Schmidt HK, Smalley RE, Curley SA, Weisman RB. 2006. Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc Natl Acad Sci U S A 103:18882–18886.
  • Churg A, Brauer M. 1997. Human lung parenchyma retains PM2.5. Am J Respir Crit Care Med 155:2109–2111.
  • Churg A, Brauer M, del Carmen Avila-Casado M, Fortoul TI, Wright JL. 2003. Chronic exposure to high levels of particulate air pollution and small airway remodeling. Environ Health Perspect 111:714–718.
  • Churg A, Brauer M, Vedal S, Stevens B. 1999. Ambient mineral particles in small airways of the normal human lung. J Environ Med 1:39–45.
  • Churg A, Wright JL. 2003. Bronchiolitis caused by occupational and ambient atmospheric particles. Semin Respir Crit Care Med 24:577–584.
  • Colton HM, Falls JG, Ni H, Kwanyuen P, Creech D, McNeil E, Casey WM, Hamilton G, Cariello NF. 2004. Visualization and quantitation of peroxisomes using fluorescent nanocrystals: Treatment of rats and monkeys with fibrates and detection in the liver. Toxicol Sci 80:183–192.
  • Cui D. 2005. Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol Lett 155:73–85.
  • Cullen RT, Tran CL, Buchanan D, Davis JM, Searl A, Jones AD, Donaldson K. 2000. Inhalation of poorly soluble particles. I. Differences in inflammatory response and clearance during exposure. Inhal Toxicol 12:1089–111.
  • Dai J, Churg A. 2001. Relationship of fiber surface iron and active oxygen species to expression of procollagen, PDGF-A, and TGF-beta(1) in tracheal explants exposed to amosite asbestos. Am J Respir Cell Mol Biol 24:427–435.
  • Dai J, Xie C, Churg A. 2002. Iron loading makes a nonfibrogenic model air pollutant particle fibrogenic in rat tracheal explants. Am J Respir Cell Mol Biol 26:685–693.
  • Dai J, Xie C, Vincent R, Churg A. 2003. Air pollution particles produce airway wall remodeling in rat tracheal explants. Am J Respir Cell Mol Biol 29(3 Pt 1):352–358.
  • Daigle CC, Chalupa DC, Gibb FR, Morrow PE, Oberdorster G, Utell MJ, Frampton MW. 2003. Ultrafine particle deposition in humans during rest and exercise. Inhal Toxicol 15:539–552.
  • de Hartog JJ, Hoek G, Peters A, Timonen KL, Ibald-Mulli A, Brunekreef B, Heinrich J, Tiittanen P, van Wijnen JH, Kreyling W, Kulmala M, Pekkanen J. 2003. Effects of fine and ultrafine particles on cardiorespiratory symptoms in elderly subjects with coronary heart disease: The ULTRA study. Am J Epidemiol 157:613–623.
  • De Villiers MM, Lvov Y. 2007. Nanoshells for drug delivery. In: Kumar C, ed. Nanomaterials for Medical Diagnosis and Therapy. Weinheim: Wiley-VCH Verlag. pp 349-423.
  • Delehanty JB, Mattoussi H, Medintz IL. 2009. Delivering quantum dots into cells: Strategies, progress and remaining issues. Anal Bioanal Chem 393:1091–105.
  • Delfino RJ, Sioutas C, Malik S. 2005. Potential role of ultrafine particles in associations between airborne particle mass and cardiovascular health. Environ Health Perspect 113:934–946.
  • DeLorenzo AJD. 1970. The old factory neuron and the blood-brain barrier. In: Wolstenholme G, Knight J, eds. Taste and Smell in Vertebrates. London: Churchill. pp 151–176.
  • Derfus AM, Chan WCW, Bhatia SN. 2004. Probing the cytoxicity of semiconductor quantum dots. Nano Lett 4:11–18.
  • Ding L, Stilwell J, Zhang T, Elboudwarej O, Jiang H, Selegue JP, Cooke PA, Gray JW, Chen FF. 2005. Molecular characterization of the cytotoxic mechanism of multiwall carbon nanotubes and nano-onions on human skin fibroblast. Nano Lett 5:2448–2464.
  • Dockery DW. 2001. Epidemiologic evidence of cardiovascular effects of particulate air pollution. Environ Health Perspect 109(Suppl 4):483–486.
  • Donaldson J. 1987. The physiopathologic significance of manganese in brain: Its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 8:451–462.
  • Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, Alexander A. 2006. Carbon nanotubes: A review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 92:5–22.
  • Donaldson K, Li XY, MacNee W. 1998. Ultrafine (nanometre) particle mediated lung injury. J Aerosol Sci 29:553–560.
  • Donaldson K, Stone V, Clouter A, Renwick L, MacNee W. 2001. Ultrafine particles. Occup Environ Med 58:211–216.
  • Donaldson K, Stone V, Seaton A, Tran L, Aitken R, Poland C. 2008. Re: Induction of mesothelioma in p53+/− mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 33:385; author reply 386–388.
  • Dresselhaus MS, Dresselhaus G. 2001. Carbon nanotubes: Synthesis, Structure, Properties, and Applications. New York, NY: Phaedon Avouris and LINK, Springer.
  • Drexler KE. 1992. Nanosystems: Molecular, Machinery, Manufacturing, and Composition. New York, NY: Wiley-Interscience Publication.
  • Driscoll KE, Costa D, Hatch G, Henderson R, Oberdorster G, Salem H, Schlesinger RB. 2000. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: Uses and limitations. Toxicol Sci 55:24–35.
  • Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. 2002. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298:1759–1762.
  • Duffin R, Tran L, Brown D, Stone V, Donaldson K. 2007. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: Highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 19:849–856.
  • Dumortier H, Lacotte S, Pastorin G, Marega R, Wu W, Bonifazi D, Briand JP, Prato M, Muller S, Bianco A. 2006. Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. Nano Lett 6:1522–1528.
  • Ekimov AI, Onushchenko AA. 1982. Quantum size effect in the optical spectra of semiconductor microcrystals. Sov Phys Semicond 16:775–777.
  • Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, Oberdorster G. 2006. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 114:1172–1178.
  • Elder A, Oberdorster G. 2006. Translocation and effects of ultrafine particles outside of the lung. Clin Occup Environ Med 5:785–796.
  • Fechter LD, Johnson DL, Lynch RA. 2002. The relationship of particle size to olfactory nerve uptake of a non-soluble form of manganese into brain. Neurotoxicology 23:177–183.
  • Ferin J. 1991. Pulmonary tissue access of ultrafine particles. J Aerosol Med 4:57–68.
  • Ferin J, Oberdorster G. 1992. Translocation of particles from the pulmonary alveoli into the interstitium. J Aerosol Med 5:179–187.
  • Ferin J, Oberdorster G, Penney DP. 1992. Pulmonary retention of ultrafine and fine particles in rats. Am J Respir Cell Mol Biol 6:535–542.
  • Finlayson-Pitts BJ, Pitts JN. 2000. Chemistry of the Upper and Lower Atmosphere: Theory, Experiments, and Applications. San Diego, CA: Academic Press. pp 527–556.
  • Foldvari M, Bagonluri M. 2008a. Carbon nanotubes as functional excipients for nanomedicines: I. Pharmaceutical properties. Nanomedicine 4:173–182.
  • Foldvari M, Bagonluri M. 2008b. Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues. Nanomedicine 4:183–200.
  • Fortina, P., L. J. Kricka, S. Surrey, and P. Grodzinski. 2005. Nanobiotechnology: the promise and reality of new approaches to molecular recognition. Trends Biotechnol 23 (4):168–73.
  • Frampton MW, Stewart JC, Oberdorster G, Morrow PE, Chalupa D, Pietropaoli AP, Frasier LM, Speers DM, Cox C, Huang LS, Utell MJ. 2006. Inhalation of ultrafine particles alters blood leukocyte expression of adhesion molecules in humans. Environ Health Perspect 114:51–58.
  • Frampton MW, Utell MJ, Zareba W, Oberdorster G, Cox C, Huang LS, Morrow PE, Lee FE, Chalupa D, Frasier LM, Speers DM, Stewart J. 2004. Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma. Boston, MA, Health Effects Institute Research Report 126. pp 1–47.
  • Gao, M., S. Huang, L. Dai, G. Wallace, R. Gao, and Z. Wang. 2000. Aligned coaxial nanowires of carbon nanotubes sheathed with conducting polymers. Angew Chem Int Ed Engl 39 (20):3664–3667.
  • Gao X, Cui Y, Levenson RM, Chung LW, Nie S. 2004. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22:969–976.
  • Gardi C, Calzoni P, Ferrali M, Comporti M. 1997. Iron mobilization from crocidolite as enhancer of collagen content in rat lung fibroblasts. Biochem Pharmacol 53:1659–1665.
  • Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P. 2005. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113:1555–60.
  • Geldenhuys WJ, Lockman PR, McAfee JH, Fitzpatrick KT, Van der Schyf CJ, Allen DD. 2004. Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter. Bioorg Med Chem Lett 14:3085–3092.
  • Ghio AJ, Zhang J, Piantadosi CA. 1992. Generation of hydroxyl radical by crocidolite asbestos is proportional to surface [Fe3+]. Arch Biochem Biophys 298:646–650.
  • Gilmour P. 1997. Surface free radical activity of PM10 and ultrafine titamium dioxide: A unifying factor in their toxicity? Ann Occup Hyg 41:32–38.
  • Gold J, Amandusson H, Krozer A, Kasemo B, Ericsson T, Zanetti G, Fubini B. 1997. Chemical characterization and reactivity of iron chelator-treated amphibole asbestos. Environ Health Perspect 105(Suppl 5):1021–1030.
  • Goldman ER, Balighian ED, Mattoussi H, Kuno MK, Mauro JM, Tran PT, Anderson GP. 2002. Avidin: A natural bridge for quantum dot-antibody conjugates. J Am Chem Soc 124:6378–6382.
  • Green GM. 1973. Alveolobronchiolar transport mechanisms. Arch Intern Med 131:109–114.
  • Han SG, Andrews R, Gairola CG, Bhalla DK. 2008. Acute pulmonary effects of combined exposure to carbon nanotubes and ozone in mice. Inhal Toxicol 20:391–398.
  • Han SK, Kim RS, Lee JH, Tae G, Cho SH, Yuk SH. 2007. Core-shell nanoparticles for drug delivery and molecular imaging. In: Kumar C, ed. Nanomaterials for Medical Diagnosis and Therapy. Weinheim: Wiley-VCH Verlag pp 143–188.
  • Hanaki K, Momo A, Oku T, Komoto A, Maenosono S, Yamaguchi Y, Yamamoto K. 2003. Semiconductor quantum dot/albumin complex is a long-life and highly photostable endosome marker. Biochem Biophys Res Commun 302:496–501.
  • Hardman R. 2006. A toxicologic review of quantum dots: Toxicity depends on physicochemical and environmental factors. Environ Health Perspect 114:165–172.
  • Hawxhurst D. 2007. Project on emerging nanotechnologies: A nanotechnology consumer products inventory. Washington DC: Woodrow Wilson International Center for Scholars. http://www.nanotechproject.org/44.
  • Hebert P. 2006. Nanotech venture capital to exceed $650 million in 2006: Lux Research, Inc. New York, NY. December 4, 2006. http://www.luxresearchinc.com/press/RELEASE_VCreport.pdf.
  • Henderson RF, Driscoll KE, Harkema JR, Lindenschmidt RC, Chang IY, Maples KR, Barr EB. 1995. A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats. Fundam Appl Toxicol 24:183–197.
  • Henriksson J, Tallkvist J, Tjalve H. 1999. Transport of manganese via the olfactory pathway in rats: Dosage dependency of the uptake and subcellular distribution of the metal in the olfactory epithelium and the brain. Toxicol Appl Pharmacol 156:119–128.
  • Hext PM. 1994. Current perspectives on particulate induced pulmonary tumours. Hum Exp Toxicol 13:700–715.
  • Hext PM, Tomenson JA, Thompson P. 2005. Titanium dioxide: Inhalation toxicology and epidemiology. Ann Occup Hyg 49:461–472.
  • Hopkins L, Pinkerton KE. 2007. Nose-to-brain translocation of inhaled nanoparticles. Toxicologist 96:234.
  • Hoshino A. 2004. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett 4:2163–2169.
  • Hu H, Haddon RC, Ni Y, Montana V, Parpura V. 2004. Chemically functionalized carbon nanotubes as substrates for neuronal growth. Nano Lett 4:507–511.
  • Hu JT, Odom TW, Lieber CM. 1999. Chemistry and physics in one dimension: Synthesis and properties of nanowires and nanotubes. Acc Chem Res 32:435–445.
  • Huang Y. 2004. Integrated nanoscale electronics and optoelectronics: Exploring nanoscale science and technology through semiconductor nanowires. Pure Appl Chem 76:2051–2068.
  • Huang, Z. 2003. Longitudinal patent analysis for nanoscale science and engineering: Country, institution and technology field. J Nanoparticle Res 5:333–363.
  • Huczko A, Lange H. 2001. Carbon nanotubes: Experimental evidence for a null risk of skin irritation and allergy. Fullerene Sci Tech 9:247–250.
  • Huczko A, Lange H, Calko E. 1999. Fullerenes: Experimental evidence for a null risk of skin irritation and allergy. Fullerene Sci Tech 7:935–939.
  • Huczko A, Lange H, Calko E, Grubek-Jaworska H, Droszcz P. 2001. Physiological testing of carbon nanotubes: Are they asbestos-like? Fullerene Sci Tech 9:251–254.
  • Hunter DD, Dey RD. 1998. Identification and neuropeptide content of trigeminal neurons innervating the rat nasal epithelium. Neuroscience 83:591–599.
  • Hunter DD, Undem BJ. 1999. Identification and Substance P content of vagal afferent neurons innervating the epithelium of the guinea pig trachea. Am J Respir Crit Care Med 159:1943–1948.
  • Ibald-Mulli A, Timonen KL, Peters A, Heinrich J, Wolke G, Lanki T, Buzorius G, Kreyling WG, de Hartog J, Hoek G, ten Brink HM, Pekkanen J. 2004. Effects of particulate air pollution on blood pressure and heart rate in subjects with cardiovascular disease: A multicenter approach. Environ Health Perspect 112:369–77.
  • Ichihara G, Castranova V, Tanioka A, Miyazawa K. 2008. Re: Induction of mesothelioma in p53+/− mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 33:381–382; author reply 382–384.
  • Idee JM, Port M, Raynal I, Schaefer M, Bonnemain B, Prigent P, Robert P, Robic C, Corot C. 2007. Superparamagnetic nanoparticles of iron oxides for magnetic resonance imaging applications. In: Kumar, ed. Nanomaterials for Medical Diagnosis and Therapy. Weinheim: Wiley-VCH Verlag. pp 51–84.
  • ILSI. 2000. The relevance of the rat lung response to particle overload for human risk assessment: A workshop consensus report. ILSI Risk Science Institute Workshop Participants. Inhal Toxicol 12:1–17.
  • Inoue K, Takano H, Yanagisawa R, Sakurai M, Ichinose T, Sadakane K, Yoshikawa T. 2005. Effects of nano particles on antigen-related airway inflammation in mice. Respir Res 6:106–118.
  • International Commission on Radiological Protection. 1994. Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection (ICRP). Ann ICRP 24:1–482.
  • Jia G, Wang H, Yan L, Wang X, Pei R, Yan T, Zhao Y, Guo X. 2005. Cytotoxicity of carbon nanomaterials: Single-wall nanotube, multi-wall nanotube, and fullerene. Environ Sci Technol 39:1378–1383.
  • Juzenas P, Chen W, Sun YP, Coelho MA, Generalov R, Generalova N, Christensen IL. 2008. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev 60:1600–1614.
  • Katz, E., and I. Willner. 2004. Biomolecule-functionalized carbon nanotubes: applications in nanobioelectronics. Chemphyschem 5 (8):1084–104.
  • Kato T, Yashiro T, Murata Y, Herbert DC, Oshikawa K, Bando M, Ohno S, Sugiyama Y. 2003. Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries. Cell Tissue Res 311:47–51.
  • Kesisoglou F, Panmai S, Wu Y. 2007. Nanosizing--oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 59:631–644.
  • Kettunen J, Lanki T, Tiittanen P, Aalto PP, Koskentalo T, Kulmala M, Salomaa V, Pekkanen J. 2007. Associations of fine and ultrafine particulate air pollution with stroke mortality in an area of low air pollution levels. Stroke 38:918–922.
  • Kooter I, Pennings J, Opperhuizen A, Cassee F. 2005. Gene expression pattern in spontaneously hypertensive rats exposed to urban particulate matter (EHC-93). Inhal Toxicol 17:53–65.
  • Kreuter J. 2001. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65–81.
  • Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdorster G, Ziesenis A. 2002. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 65:1513–1530.
  • Kreyling WG, Semmler M, Moller W. 2004. Dosimetry and toxicology of ultrafine particles. J Aerosol Med 17:140–152.
  • Kreyling WG, Semmler-Behnke M, Moller W. 2006. Ultrafine particle-lung interactions: Does size matter? J Aerosol Med 19:74–83.
  • Ku BK, Maynard AD. 2005. Comparing aerosol surface-area measurements of monodisperse ultrafine silver agglomerates by mobility analysis, transmission electron microscopy and diffusion charging. J Aerosol Sci 36:1108–1124.
  • Ku BK, Maynard AD. 2006. Generation and investigation of airborne silver nanoparticles with specific size and morphology by homogeneous nucleation, coagulation and sintering. J Aerosol Sci 37:452–470.
  • Lam CW, James JT, McCluskey R, Arepalli S, Hunter RL. 2006. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol 36:189–217.
  • Lam CW, James JT, McCluskey R, Hunter RL. 2004. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77:126–134.
  • Leong BK, Coombs JK, Sabaitis CP, Rop DA, Aaron CS. 1998. Quantitative morphometric analysis of pulmonary deposition of aerosol particles inhaled via intratracheal nebulization, intratracheal instillation or nose-only inhalation in rats. J Appl Toxicol 18:149–160.
  • Li JG, Li WX, Xu JY, Cai XQ, Liu RL, Li YJ, Zhao QF, Li QN. 2007a. Comparative study of pathological lesions induced by multiwalled carbon nanotubes in lungs of mice by intratracheal instillation and inhalation. Environ Toxicol 22:415–21.
  • Li Z, Hulderman T, Salmen R, Chapman R, Leonard SS, Young SH, Shvedova S, Luster MI, Simeonova PP. 2007b. Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ Health Perspect 115:377–382.
  • Li ZJ. 2005. Pulmonary exposure to carbon nanotubes induces vascular toxicity. Toxicologist 84:213.
  • Li ZJ. 2006. Relationship between pulmonary exposure to multiple doses of single wall carbon nanotubes and atherosclerosis in ApoE −/− mouse model. Toxicologist 90:318.
  • Lidke DS, Nagy P, Heintzmann R, Arndt-Jovin DJ, Post JN, Grecco HE, Jares-Erijman EA, Jovin TM. 2004. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat Biotechnol 22:198–203.
  • Lieber C. 2003. Nanoscale science and technology: Building a big future from small things. MRS Bull 28:486–491.
  • Limbach LK, Li Y, Grass RN, Brunner TJ, Hintermann MA, Muller M, Gunther D, Stark WJ. 2005. Oxide nanoparticle uptake in human lung fibroblasts: Effects of particle size, agglomeration, and diffusion at low concentrations. Environ Sci Technol 39:9370–9376.
  • Lingerfelt BM, Mattoussi H, Goldman ER, Mauro JM, Anderson GP. 2003. Preparation of quantum dot-biotin conjugates and their use in immunochromatography assays. Anal Chem 75:4043–4048.
  • Lison D, Thomassen LC, Rabolli V, Gonzalez L, Napierska D, Seo JW, Kirsch-Volders M, Hoet P, Kirschhock CE, Martens JA. 2008. Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. Toxicol Sci 104:155–162.
  • Lockman PR, Koziara JM, Mumper RJ, Allen DD. 2004a. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 12:635–641.
  • Lockman PR, McAfee JH, Geldenhuys WJ, Allen DD. 2004b. Cation transport specificity at the blood-brain barrier. Neurochem Res 29:2245–2250.
  • Lovat V, Pantarotto D, Lagostena L, Cacciari B, Grandolfo M, Righi M, Spalluto G, Prato M, Ballerini L. 2005. Carbon nanotube substrates boost neuronal electrical signaling. Nano Lett 5:1107–1110.
  • Lux Research, Inc. 2006. The Nanotech Report. New York, NY: Lux Research, Inc.
  • Magrez A, Kasas S, Salicio V, Pasquier N, Seo JW, Celio M, Catsicas S, Schwaller B, Forro L. 2006. Cellular toxicity of carbon-based nanomaterials. Nano Lett 6:1121–1125.
  • Mahtab R, Rogers JP, Murphy CJ. 1995. Protein-sized quantum-dot luminescence can distinguish between straight, bent, and kinked oligonucleotides. J Am Chem Soc 117:9099–9100.
  • Manna SK, Sarkar S, Barr J, Wise K, Barrera EV, Jejelowo O, Rice-Ficht AC, Ramesh GT. 2005. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappaB in human keratinocytes. Nano Lett 5:1676–1684.
  • Mattson MP, Haddon RC, Rao AM. 2000. Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth. J Mol Neurosci 14:175–182.
  • Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V. 2004. Exposure to carbon nanotube material: Aerosol release during the handling of unrefined single-walled carbon nanotube material. J Toxicol Environ Health A 67:87–107.
  • Maynard AD, Kuempel ED. 2005. Airborne nanostructured particles and occupational health. J Nanopart Res 7:587–614.
  • Mercer RR, Scabilloni J, Wang L, Kisin E, Murray AR, Schwegler-Berry D, Shvedova AA, Castranova V. 2008. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am J Physiol Lung Cell Mol Physiol 294:L87–L97.
  • Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S. 2005. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307:538–544.
  • Mills NL. 2005. Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med 173:426–431.
  • Mills NL, Tornqvist H, Gonzalez MC, Vink E, Robinson SD, Soderberg S, Boon NA, Donaldson K, Sandstrom T, Blomberg A, Newby DE. 2007. Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. N Engl J Med 357:1075–82.
  • Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, Boon NA, Donaldson K, Blomberg A, Sandstrom T, Newby DE. 2005. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation 112 (25):3930–6.
  • Mitchell LA, Gao J, Wal RV, Gigliotti A, Burchiel SW, McDonald JD. 2007. Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol Sci 100:203–214.
  • Moller W, Seitz J, Sommerer K, Heyder J, Kreyling WG. 2003. Deposition and clearance of radiolabelled ultrafine carbon particles in the human airways after bolus inhalation. J Aerosol Med 16:201.
  • Monteiller C, Tran L, MacNee W, Faux S, Jones A, Miller B, Donaldson K. 2007. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: The role of surface area. Occup Environ Med 64:609–615.
  • Monteiro-Riviere NA, Nemanich RJ, Inman AO, Wang YY, Riviere JE. 2005. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 155:377–384.
  • Mor G, Shankar K, Paulose M, Varghese O, Grimes C. 2006. Use of highly-ordered TiO2 nanotube arrays in dye-sensitized solar cells. Nano Lett 6:215–218.
  • Muller J, Delos M, Panin N, Rabolli V, Huaux F, Lison D. 2009. Absence of carcinogenic response to multi-wall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicol Sci 110:442–448.
  • Muller J, Huaux F, Fonseca A, Nagy JB, Moreau N, Delos M, Raymundo-Pinero E, Beguin F, Kirsch-Volders M, Fenoglio I, Fubini B, Lison D. 2008. Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: Toxicological aspects. Chem Res Toxicol 21:1698–705.
  • Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, Arras M, Fonseca A, Nagy JB, Lison D. 2005. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 207:221–231.
  • Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. 2008. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101:239–253.
  • Navrotsky A. 2001. Thermochemistry of nanomaterials. Nanoparticles Environ 44:73–103.
  • Nemmar A. 2002. Passage of inhaled particles into the blood circulation in humans. Circulation 105:411–414.
  • NIOSH. 2005. Current intelligence bulletin: Evaluation of health hazard and recommendations for occupational exposure to titanium dioxide (draft). Atlanta, GA: National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control & Prevention, Department of Human and Health Services.
  • NNI. 2007. Funding opportunities: National Nanotechnology Initiative, Washington DC. http://www.nano.gov/html/funding/home_funding.html.
  • Nordenhall C, Pourazar J, Blomberg A, Levin JO, Sandstrom T, Adelroth E. 2000. Airway inflammation following exposure to diesel exhaust: A study of time kinetics using induced sputum. Eur Respir J 15:1046–1051.
  • Oberdorster G. 1996. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. Inhal Toxicol 8(Suppl):73–89.
  • Oberdorster G, Ferin J, Gelein R, Soderholm SC, Finkelstein J. 1992. Role of the alveolar macrophage in lung injury: Studies with ultrafine particles. Environ Health Perspect 97:193–199.
  • Oberdorster G, Ferin J, Lehnert BE. 1994. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 102(Suppl 5):173–179.
  • Oberdorster G, Gelein RM, Ferin J, Weiss B. 1995. Association of particulate air pollution and acute mortality: Involvement of ultrafine particles? Inhal Toxicol 7:111–124.
  • Oberdorster G, Oberdorster E, Oberdorster J. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839.
  • Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. 2004. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437–445.
  • Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C. 2002. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 65:1531–1543.
  • Oberdorster G, Utell MJ. 2002. Ultrafine particles in the urban air: To the respiratory tract—and beyond? Environ Health Perspect 110:A440–A441.
  • OECD. 2008. List of manufactured nanomaterials and list of endpoints for phase one of the OECD testing programme. Paris, France: Environment Directorate Joint Meeting of the Chemicals Committee and the Working Party on Chemicals, Pesticides and Biotechnology, Organisation for Economic Co-operation and Development. ENV/JM/MONO(2008)13.
  • Osaki F, Kanamori T, Sando S, Sera T, Aoyama Y. 2004. A quantum dot conjugated sugar ball and its cellular uptake on the size effects of endocytosis in the subviral region. J Am Chem Soc 126:6520–6521.
  • Osier M, Baggs RB, Oberdorster G. 1997. Intratracheal instillation versus intratracheal inhalation: Influence of cytokines on inflammatory response. Environ Health Perspect 105(Suppl 5):1265–1271.
  • Osier M, Oberdorster G. 1997. Intratracheal inhalation vs intratracheal instillation: Differences in particle effects. Fundam Appl Toxicol 40:220–227.
  • Park EJ, Brasuel M, Behrend C, Philbert MA, Kopelman R. 2003a. Ratiometric optical PEBBLE nanosensors for real-time magnesium ion concentrations inside viable cells. Anal Chem 75 (15):3784–3791.
  • Park KH, Chhowalla M, Iqbal Z, Sesti F. 2003b. Single-walled carbon nanotubes are a new class of ion channel blockers. J Biol Chem 278:50212–50216.
  • Patolsky F. 2005. Nanowire nanosensors. Materials Today 8:20–28.
  • Patolsky F, Zheng G, Lieber CM. 2006. Nanowire sensors for medicine and the life sciences. Nanomedicine 1:51–65.
  • Pekkanen J, Peters A, Hoek G, Tittanen P, Brunekreef B, de Hartog J, Heinrich J, Ibald-Mulli A, Kreyling WG, Lanki T, Timonen KL, Vanninen E. 2002. Particulate air pollution and risk of ST-segment depression during repeated submaximal exercise tests among subjects with coronary heart disease: The exposure and risk assessment for fine and ultrafine particles in ambien air. Circulation 106:933–938.
  • Pellegrino T, Manna L, Kudera S, Liedl T, Koktysh D, Rogach AL, Keller S, Radler J, Natile G, Parak WJ. 2004. Hydrophobic nanocrystals coated with amphiphilic polymer shell: A general route to water soluble nanocrystals. Nano Lett 4:703–707.
  • Persson E, Henriksson J, Tallkvist J, Rouleau C, Tjalve H. 2003. Transport and subcellular distribution of intranasally administered zinc in the olfactory system of rats and pikes. Toxicology 191:97–108.
  • Peters A, Veronesi B, Calderon-Garciduenas L, Gehr P, Chen LC, Geiser M, Reed W, Rothen-Rutishauser B, Schurch S, Schulz H. 2006. Translocation and potential neurological effects of fine and ultrafine particles a critical update. Part Fibre Toxicol 3:1–13.
  • Pietropaoli AP, Frampton MW, Hyde RW, Morrow PE, Oberdorster G, Cox C, Speers DM, Frasier LM, Chalupa DC, Huang LS, Utell MJ. 2004. Pulmonary function, diffusing capacity, and inflammation in healthy and asthmatic subjects exposed to ultrafine particles. Inhal Toxicol 16(Suppl 1):59–72.
  • Pinkerton KE, Green FH, Saiki C, Vallyathan V, Plopper CG, Gopal V, Hung D, Bahne EB, Lin SS, Menache MG, Schenker MB. 2000. Distribution of particulate matter and tissue remodeling in the human lung. Environ Health Perspect 108:1063–1069.
  • Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V, Brown S, Macnee W, Donaldson K. 2008. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3:423–428.
  • Pope CA 3rd. 2000. Epidemiology of fine particulate air pollution and human health: Biologic mechanisms and who’s at risk? Environ Health Perspect 108(Suppl 4):713–723.
  • Powers KW. 2006. Research strategies for safety evaluation of nanomaterials part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci 90:296–303.
  • Qu Y, Porter R, Shan F, Carter J, Guo T. 2006. Synthesis of tubular gold and silver nanoshells using silica nanowire core templates. Langmuir 22:6367–6374.
  • Rao GV, Tinkle S, Weissman DN, Antonini JM, Kashon ML, Salmen R, Battelli LA, Willard PA, Hoover MD, Hubbs AF. 2003. Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx. J Toxicol Environ Health A 66:1441–1452.
  • Renwick LC, Donaldson K, Clouter A. 2001. Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol Appl Pharmacol 172:119–127.
  • Rieger J, Jerome C, Jerome R, Auzely-Velty R. 2007. Polymeric nanomaterials—Synthesis, functionalization and applications in diagnosis and therapy. In: Kumar C, ed. Nanomaterials for Medical Diagnosis and Therapy. Weinheim: Wiley-VCH Verlag pp 342–408.
  • Rimai DS, Quesnel DJ, Busnaina AA. 2000. The adhesion of dry particles in the nanometer to micrometer-size range. Coll Surf A Physicochem Eng Aspects 165:3–10.
  • Rinderknecht A, Elder A, Prud’homme R, Gindy M, Oberdörster G. 2007. Are poly(ethylene glycol)-functionalized nanoparticles biocompatible? Toxicologist 96:232.
  • Roth C. 1994. Clearance measurements with radioactively labelled ultrafine particles. Ann Occup Hyg 38:101–106.
  • Roth C. 1997. Deposition and clearance of fine particles in the human respiratory tract. Ann Occup Hyg 40:503–508.
  • Roth C, Scheuch G, Stahlhofen W. 1993. Clearance of the human lungs for ultrafine partcles. J Aerosol Sci 24:S95–S96.
  • Ruckerl R, Phipps RP, Schneider A, Frampton M, Cyrys J, Oberdorster G, Wichmann HE, Peters A. 2007. Ultrafine particles and platelet activation in patients with coronary heart disease—Results from a prospective panel study. Partice Fibre Toxicol 4:1–14.
  • Rudell B, Sandström T, Stjernberg N, Kolmodin-Hedman B. 1990. Controlled diesel exhaust exposure in an exposure chamber: Pulmonary effects investigated with bronchoalveolar lavage. J Aerosol Sci 21 (Suppl 1):S41–S414.
  • Rudell B, Ledin MC, Hammarstrom U, Stjernberg N, Lundback B, Sandstrom T. 1996. Effects on symptoms and lung function in humans experimentally exposed to diesel exhaust. Occup Environ Med 53:658–662.
  • Rudell B, Sandstrom T, Hammarstrom U, Ledin ML, Horstedt P, Stjernberg N. 1994. Evaluation of an exposure setup for studying effects of diesel exhaust in humans. Int Arch Occup Environ Health 66:77–83.
  • Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. 2006. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 91:159–165.
  • Ryman-Rasmussen JP, Tewksbury EW, Moss OR, Cesta MF, Wong BA, Bonner JC. 2008. Inhaled multi-walled carbon nanotubes potentiate airway fibrosis in murine allergic asthma. Am J Respir Cell Mol Biol. 40:348–358.
  • Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL. 2000. Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. N Engl J Med 343:1742–1749.
  • Sayes CM, Fortner JD, Guo W, Lyon D, Boyd AM, Ausman KD, Tao YJ, Sitharaman B, Wilson LJ, Hughes JB, West JL, Colvin VL. 2004. The differential cytotoxicity of water-soluble fullerenes. Nano Lett 4:1881–1887.
  • Sayes CM, Marchione AA, Reed KL, Warheit DB. 2007. Comparative pulmonary toxicity assessments of C60 water suspensions in rats: Few differences in fullerene toxicity in vivo in contrast to in vitro profiles. Nano Lett 7:2399–2406.
  • Sayes CM, Wahi R, Kurian PA, Liu Y, West JL, Ausman KD, Warheit DB, Colvin VL. 2006. Correlating nanoscale titania structure with toxicity: A cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol Sci 92:174–185.
  • Schipper ML, Nakayama-Ratchford N, Davis CR, Kam NW, Chu P, Liu Z, Sun X, Dai H, Gambhir SS. 2008. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat Nanotechnol 3:216–221.
  • Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdorster G, Kreyling WG. 2004. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol 16:453–459.
  • Semmler-Behnke M, Takenaka S, Fertsch S, Wenk A, Seitz J, Mayer P, Oberdorster G, Kreyling WG. 2007. Efficient elimination of inhaled nanoparticles from the alveolar region: Evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect 115:728–733.
  • Shvedova AA, Castranova V, Kisin ER, Schwegler-Berry D, Murray AR, Gandelsman VZ, Maynard A, Baron P. 2003. Exposure to carbon nanotube material: Assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A 66:1909–1926.
  • Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK, Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P. 2005. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289:L698–L708.
  • Shvedova AA, Kisin ER, Murray AR, Gorelik O, Arepalli S, Castranova V, Young SH, Gao F, Tyurina YY, Oury TD, Kagan VE. 2007. Vitamin E deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57BL/6 mice. Toxicol Appl Pharmacol 221:339–348.
  • Shvedova AA, Kisin E, Murray AR, Johnson VJ, Gorelik O, Arepalli S, Hubbs AF, Mercer RR, Keohavong P, Sussman N, Jin J, Yin J, Stone S, Chen BT, Deye G, Maynard A, Castranova V, Baron PA, Kagan VE. 2008. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: Inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol 295:L552–L565.
  • Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, Prato M, Bianco A, Kostarelos K. 2006. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci U S A 103:3357–3362.
  • Sint T, Donohue JF, Ghio AJ. 2008. Ambient air pollution particles and the acute exacerbation of chronic obstructive pulmonary disease. Inhal Toxicol 20:25–29.
  • Smalley R. 2001. Wires of wonder. Technol Rev 104:86–91.
  • Smith KR, Kim S, Recendez JJ, Teague SV, Menache MG, Grubbs DE, Sioutas C, Pinkerton KE. 2003. Airborne particles of the california central valley alter the lungs of healthy adult rats. Environ Health Perspect 111:902–908; discussion A408–A409.
  • Takagi A, Hirose A, Nishimura T, Fukumori N, Ogata A, Ohashi N, Kitajima S, Kanno J. 2008. Induction of mesothelioma in p53+/− mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 33:105–116.
  • Takenaka S, Karg E, Kreyling WG, Lentner B, Moller W, Behnke-Semmler M, Jennen L, Walch A, Michalke B, Schramel P, Heyder J, Schulz H. 2006. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol 18:733–740.
  • Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG. 2007. Particokinetics in vitro: Dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol Sci 95:300–312.
  • Tian F, Cui D, Schwarz H, Estrada GG, Kobayashi H. 2006. Cytotoxicity of single-wall carbon nanotubes on human fibroblasts. Toxicol In Vitro 20:1202–1212.
  • Timonen KL, Vanninen E, de Hartog J, Ibald-Mulli A, Brunekreef B, Gold DR, Heinrich J, Hoek G, Lanki T, Peters A, Tarkiainen T, Tiittanen P, Kreyling W, Pekkanen J. 2006. Effects of ultrafine and fine particulate and gaseous air pollution on cardiac autonomic control in subjects with coronary artery disease: The ULTRA study. J Expo Sci Environ Epidemiol 16:332–41.
  • Tjalve H, Henriksson J, Tallkvist J, Larsson BS, Lindquist NG. 1996. Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. Pharmacol Toxicol 79:347–356.
  • Tjalve H, Mejare C, Borg-Neczak K. 1995. Uptake and transport of manganese in primary and secondary olfactory neurones in pike. Pharmacol Toxicol 77:23–31.
  • Tong H, McGee JK, Saxena RK, Kodavanti UP, Devlin RB, Gilmour MI. 2009. Influence of acid functionalization on the cardiopulmonary toxicity of carbon nanotubes and carbon black particles in mice. Toxicol Appl Pharmacol doi:10.1016/j.taap.2009.05.019.
  • Tornqvist H, Mills NL, Gonzalez M, Miller MR, Robinson SD, Megson IL, Macnee W, Donaldson K, Soderberg S, Newby DE, Sandstrom T, Blomberg A. 2007. Persistent endothelial dysfunction in humans after diesel exhaust inhalation. Am J Respir Crit Care Med 176:395–400.
  • Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K. 2000. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal Toxicol 12:1113–1126.
  • Tsay JM, Michalet X. 2005. New light on quantum dot cytotoxicity. Chem Biol 12:1159–1161.
  • Usui Y, Aoki K, Narita N, Murakami N, Nakamura I, Nakamura K, Ishigaki N, Yamazaki H, Horiuchi H, Kato H, Taruta S, Kim YA, Endo M, Saito N. 2008. Carbon nanotubes with high bone-tissue compatibility and bone-formation acceleration effects. Small 4:240–246.
  • Veranth JM, Cutler NS, Kaser EG, Reilly CA, Yost GS. 2008. Effects of cell type and culture media on Interleukin-6 secretion in response to environmental particles. Toxicol In Vitro 22:498–509.
  • Warheit DB. 2008. How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci 101:183–185.
  • Warheit DB, Brock WJ, Lee KP, Webb TR, Reed KL. 2005. Comparative pulmonary toxicity inhalation and instillation studies with different TiO2 particle formulations: Impact of surface treatments on particle toxicity. Toxicol Sci 88:514–524.
  • Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR. 2004. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 77:117–125.
  • Warheit DB, Webb TR, Reed KL. 2006a. Pulmonary toxicity screening studies in male rats with TiO2 particulates substantially encapsulated with pyrogenically deposited, amorphous silica. Part Fibre Toxicol 3:3–12.
  • Warheit DB, Webb TR, Reed KL, Frerichs S, Sayes CM. 2007. Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: Differential responses related to surface properties. Toxicology 230:90–104.
  • Warheit DB, Webb TR, Sayes CM, Colvin VL, Reed KL. 2006b. Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: Toxicity is not dependent upon particle size and surface area. Toxicol Sci 91:227–236.
  • Weitzman SA, Chester JF, Graceffa P. 1988. Binding of deferoxamine to asbestos fibers in vitro and in vivo. Carcinogenesis 9:1643–1645.
  • Weitzman SA, Weitberg AB. 1985. Asbestos-catalysed lipid peroxidation and its inhibition by desferroxamine. Biochem J 225 (1):259–62.
  • West JL, Halas NJ. 2003. Engineered nanomaterials for biophotonics applications: Improving sensing, imaging, and therapeutics. Ann Rev Biomed Eng 5:285–292.
  • Whitby KT, Sverdrup GM. 1980. California aerosols: Their physical and chemical characteristics. Adv Environ Sci Technol 8:477–525.
  • Wick P, Manser P, Limbach LK, Dettlaff-Weglikowska U, Krumeich F, Roth S, Stark WJ, Bruinink A. 2007. The degree and kind of agglomeration affect carbon nanotube cytotoxicity. Toxicol Lett 168:121–131.
  • Wiebert P, Sanchez-Crespo A, Seitz J, Falk R, Philipson K, Kreyling WG, Moller W, Sommerer K, Larsson S, Svartengren M. 2006. Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur Respir J 28:286–290.
  • Williams KA, Veenhuizen PTM, de la Torre BG, Eritja R, Dekker C. 2002. Nanotechnology—Carbon nanotubes with DNA recognition. Nature 420:761.
  • Wu X, Liu H, Liu J, Haley KN, Treadway JA, Larson JP, Ge N, Peale F, Bruchez MP. 2003. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 21:41–46.
  • Yamaguchi Y, Igarashi R. 2007. NANOEGG technology for drug delivery. In: Kumar C, ed. Nanomaterials for Medical Diagnosis and Therapy. Weinheim: Wiley-VCH Verlag pp 310–341.
  • Yamamoto A, Honma R, Sumita M, Hanawa T. 2003. Cytotoxicity evaluation of ceramic particles of different sizes and shapes. J Biomed Mater Res A 68:244–256.
  • Zavaleta C, de la Zerda A, Liu Z, Keren S, Cheng Z, Schipper M, Chen X, Dai H, Gambhir SS. 2008. Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes. Nano Lett 8:2800–285.
  • Zhang T, Stilwell JL, Gerion D, Ding L, Elboudwarej O, Cooke PA, Gray JW, Alivisatos AP, Chen FF. 2006. Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements. Nano Lett 6:800–808.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.